21/01/2026
American scientists reversed vocal cord scarring regenerating voice quality through collagen injections. Researchers at Vanderbilt University developed injectable recombinant human collagen that integrates into scarred vocal cords, restoring the layered structure essential for voice production. Professional singers, teachers, and others who lost voice quality to scarring, surgery, or injury regained normal or near-normal vocal function.
Vocal cord scarring from surgery, injury, or overuse disrupts the delicate layered structure necessary for proper vibration. Scar tissue is stiff, preventing the smooth wave-like motion that creates voice. Patients experience hoarseness, vocal fatigue, reduced range, and voice breaks. Traditional treatments—voice therapy and surgery—provide limited improvement because they can't restore native tissue structure. Vanderbilt's approach regenerates the actual layered anatomy.
The treatment uses recombinant human collagen I and III—the specific types naturally present in vocal cord layers—combined with hyaluronic acid matching native tissue composition. Injected into scarred areas through the mouth using specialized laryngeal instruments, the biomaterial integrates with existing tissue, providing a scaffold for cellular regeneration. Over months, patient's own cells infiltrate the material, replacing scar tissue with properly organized collagen.
Trials with 67 patients having severe vocal cord scarring showed 78% achieved significant voice improvement—restored vocal range, eliminated hoarseness, and regained vocal stamina. Professional opera singers returned to performing; teachers could lecture full days without strain. Acoustic analysis confirmed restoration of normal vocal cord vibration patterns. One Broadway performer who'd retired due to vocal damage returned to stage after five years. We're regenerating one of the most delicate and complex tissue structures, returning voices to those who'd lost their ability to speak or sing properly.
Source: Vanderbilt University Medical Center, The Laryngoscope 2025